# Sewon Cellontech signs exclusive Asia-Pacific supply deal with J&J MedTech

Sewon Cellontech (CG Bio) signed an exclusive supply agreement with Johnson & Johnson MedTech for its Novosis bone graft products in six Asia-Pacific countries, with export value over KRW 25 billion over five years.

- Type: Contract
- Announced: 2025-02-17
- Where: South Korea
- Value: $19.0M (25.0B KRW)
- Status: announced
- Products: Novosis bone graft, Novosis Putty
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Sewon Cellontech](https://endata.com/companies/6152.md)
- [Johnson & Johnson MedTech](https://endata.com/companies/70243.md) (customer)

## Sources

- [mt.co.kr](https://www.mt.co.kr/thebio/2025/02/17/2025021716010528937), 2025-02-17: "존슨앤드존슨(J&J) 메드테크와 자사 골대체제 '노보시스' 제품군의 아시아태평양 지역 독점 공급 계약을 체결했습니다"

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.